Reason for request
Renouvellement d'inscription
Clinical Benefit
| Substantial |
La Commission considère que le service médical rendu par CHIBROXINE, 0,3 % reste important dans les indications de l'AMM.
|
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
z6z1qjUn83abnh2u
Listen
